Datasets:

Suchinthana
/

support2-1

Dataset card Data Studio Files Files and versions Community

Split (1)

train · 9.11k rows

ID int64 1 9.11k	age float64 18 102	death int64 0 1	sex stringclasses 2 values	hospdead int64 0 1	slos int64 3 343	d.time int64 3 2.03k	dzgroup stringclasses 8 values	dzclass stringclasses 4 values	num.co int64 0 9	edu float64 0 31 ⌀	income stringclasses 4 values	scoma float64 0 100 ⌀	charges float64 1.17k 1.44M ⌀	totcst float64 0 633k ⌀	totmcst float64 -102.72 711k ⌀	avtisst float64 1 83 ⌀	race stringclasses 5 values	sps float64 0.2 99.2 ⌀	aps float64 0 143 ⌀	surv2m float64 0 0.97 ⌀	surv6m float64 0 0.95 ⌀	hday int64 1 148	diabetes int64 0 1	dementia int64 0 1	ca stringclasses 3 values	prg2m float64 0 1 ⌀	prg6m float64 0 1 ⌀	dnr stringclasses 3 values	dnrday float64 -88 285 ⌀	meanbp float64 0 195 ⌀	wblc float64 0 200 ⌀	hrt float64 0 300 ⌀	resp float64 0 90 ⌀	temp float64 31.7 41.7 ⌀	pafi float64 12 890 ⌀	alb float64 0.4 29 ⌀	bili float64 0.1 63 ⌀	crea float64 0.1 21.5 ⌀	sod float64 110 181 ⌀	ph float64 6.83 7.77 ⌀	glucose float64 0 1.09k ⌀	bun float64 1 300 ⌀	urine float64 0 9k ⌀	adlp float64 0 7 ⌀	adls float64 0 7 ⌀	sfdm2 stringclasses 5 values	adlsc float64 0 7.07
2,801	78.44995	1	male	0	9	107	CHF	COPD/CHF/Cirrhosis	5	12	null	0	25,633	15,443.7422	14,184.5	10.5	white	21.597656	33	0.694946	0.530884	6	0	0	yes	0.3	0.05	no dnr	9	97	6.599609	60	20	36.09375	224	null	null	0.699951	141	7.299805	183	7	null	0	0	no(M2 and SIP pres)	0
2,802	73.37994	0	female	0	4	782	CHF	COPD/CHF/Cirrhosis	3	9	null	0	4,327	2,242.1426	2,075.13867	16	white	16.5	29	0.873901	0.790894	1	1	0	no	0.9	0.8	no dnr	4	80	13.5	180	20	36.09375	260	null	null	0.699951	138	7.419922	82	8	850	0	null	no(M2 and SIP pres)	0.494751
2,803	73.89697	1	male	0	9	29	CHF	COPD/CHF/Cirrhosis	2	17	$25-$50k	0	13,112	7,688.0469	6,305.33984	13	white	18.898438	29	0.846924	0.748901	1	0	0	no	0.95	0.9	no dnr	9	39	31.398438	118	28	37.29688	70	1.5	0.599976	2.5	136	7.109375	230	51	50	0	1	<2 mo. follow-up	1
2,804	41.91898	0	male	0	21	780	ARF/MOSF w/Sepsis	ARF/MOSF	0	15	$25-$50k	0	86,133	59,003.0312	41,610.25	40.333313	white	28	28	0.827881	0.768921	1	0	0	no	0.7	0.7	no dnr	21	65	17.597656	116	16	37.89844	null	2.099609	2.099609	1.099854	132	null	109	29	450	null	0	no(M2 and SIP pres)	0
2,805	81.16595	1	male	0	28	32	Lung Cancer	Cancer	2	24	$25-$50k	9	32,597	18,775.0156	23,421.4219	9.25	white	18.796875	22	0.587891	0.267944	1	1	0	metastatic	0.8	0.3	dnr after sadm	7	107	7.299805	72	24	36.89844	262.9375	null	null	2.199707	139	7.40918	129	54	1,450	null	4	<2 mo. follow-up	4
2,806	22.63399	0	male	0	154	779	ARF/MOSF w/Sepsis	ARF/MOSF	3	12	>$50k	0	489,823	279,177.75	236,234.5	51.5	white	35.695313	50	0.783936	0.713989	1	0	0	no	0.6	0.5	no dnr	154	127	20.296875	130	40	38.19531	132	2.099609	null	0.599976	146	7.439453	111	9	1,016	null	0	Coma or Intub	0
2,807	84.49298	1	female	0	86	206	ARF/MOSF w/Sepsis	ARF/MOSF	4	null	null	0	183,705	null	null	37.25	white	19.699219	54	0.700928	0.610962	1	1	0	metastatic	0.8	0.5	no dnr	86	111	17.699219	105	16	35.59375	195.21875	3.799805	0.599976	4.699219	132	7.489258	119	23	0	null	null	adl>=4 (>=5 if sur)	3.76416
2,808	18.754	0	female	0	8	777	ARF/MOSF w/Sepsis	ARF/MOSF	0	13	null	0	15,711	11,459.125	9,782.89844	16	other	28.796875	38	0.878906	0.835938	1	0	0	no	0.98	0.98	no dnr	8	124	16.097656	50	24	38.5	105	null	null	1.5	142	7.399414	172	35	1,664	0	1	no(M2 and SIP pres)	1
2,809	77.05695	1	male	0	11	70	MOSF w/Malig	ARF/MOSF	3	16	null	0	23,606	13,628.6641	13,242.6562	13	white	24.097656	37	0.616943	0.511963	6	1	0	yes	0.6	0.5	no dnr	11	52	7	120	29	36.79688	95.90625	null	null	0.899902	131	7.489258	95	17	4,300	1	0	no(M2 and SIP pres)	0
2,810	82.86395	1	male	1	6	6	ARF/MOSF w/Sepsis	ARF/MOSF	1	null	null	41	26,475	15,379.2031	8,938.91406	24	white	28.5	52	0.457947	0.337952	1	1	0	no	0.2	0.2	dnr after sadm	2	63	16.398438	60	4	36.59375	65	null	0.299988	0.799927	145	7.329102	253	15	2,275	null	null	<2 mo. follow-up	3.026367
2,811	64.81598	0	female	0	79	776	ARF/MOSF w/Sepsis	ARF/MOSF	1	16	$11-$25k	0	227,656	150,149	134,263.625	41	white	26.398438	24	0.714966	0.62793	8	0	0	no	0.8	0.75	no dnr	79	67	7.299805	80	20	37	271.375	2.899902	6.5	1.5	140	7.469727	183	21	1,200	null	5	adl>=4 (>=5 if sur)	5
2,812	91.25	1	female	0	7	10	Lung Cancer	Cancer	3	12	null	0	6,621	3,815.6055	715.7998	3	white	24.199219	43	0.449951	0.13797	1	0	0	metastatic	0.6	0.2	dnr after sadm	3	59	5	120	24	35.79688	261.875	null	null	3.799805	139	7.279297	88	86	490	2	3	<2 mo. follow-up	3
2,813	73.54999	1	male	0	16	43	MOSF w/Malig	ARF/MOSF	3	12	under $11k	0	37,467	26,889.4062	21,578.0469	17	white	28.597656	61	0.498962	0.381958	1	0	0	metastatic	0.85	0.6	dnr after sadm	14	77	8.699219	70	25	36.69531	305	2.299805	1.099854	1.099854	140	7.479492	106	14	4,745	1	1	<2 mo. follow-up	1
2,814	84.64899	1	female	1	3	3	Coma	Coma	1	12	under $11k	100	10,739	5,883.5078	4,961.9375	34	white	36	64	0.001	0	1	0	0	no	null	null	dnr after sadm	3	60	14.699219	1	40	36.89844	100	2	1.899902	2.099609	136	7.449219	172	26	972	null	null	<2 mo. follow-up	3.404785
2,815	34.45898	0	male	0	3	773	CHF	COPD/CHF/Cirrhosis	3	null	null	0	3,212	1,865.0439	1,924.53906	null	black	9.898438	19	0.966919	0.942993	1	0	0	no	null	null	no dnr	3	51	4.5	79	25	36.09375	null	null	0.5	1.199951	138	null	101	16	750	null	null	no(M2 and SIP pres)	1.723633
2,816	94.28894	0	female	0	18	772	ARF/MOSF w/Sepsis	ARF/MOSF	2	12	null	0	4,854	35,284.0938	24,298.8594	24.333328	white	18.898438	25	0.778931	0.707886	1	0	0	no	0.7	0.6	no dnr	18	120	7.699219	70	20	35.59375	null	null	null	1.099854	137	null	250	21	1,000	null	1	adl>=4 (>=5 if sur)	1
2,817	65.65594	0	female	0	5	771	ARF/MOSF w/Sepsis	ARF/MOSF	1	20	>$50k	0	14,770	10,889.8672	8,702.69531	19	white	25.898438	24	0.748901	0.669922	3	0	0	no	1	1	no dnr	5	105	12	60	24	36.59375	null	3.799805	1.799805	1.899902	139	null	124	44	1,175	null	null	no(M2 and SIP pres)	1.952148
2,818	77.14697	0	male	0	3	769	ARF/MOSF w/Sepsis	ARF/MOSF	1	16	under $11k	0	6,100	3,419.4824	3,175.78906	null	white	23.097656	51	0.777954	0.705933	1	0	0	no	1	0.9	no dnr	3	79	12.599609	106	30	38.09375	106.65625	2.699707	0.199982	0.699951	133	7.389648	101	13	7,130	1	0	no(M2 and SIP pres)	0
2,819	63.17899	1	male	0	3	426	CHF	COPD/CHF/Cirrhosis	4	22	>$50k	0	4,222	2,193.7207	2,169.21875	null	white	16.296875	19	0.873901	0.789917	1	0	0	yes	0.85	0.5	no dnr	3	73	8	80	16	36.09375	null	3.199707	null	1.299805	142	null	61	27	1,770	null	null	no(M2 and SIP pres)	2.115723
2,820	69.42395	1	male	0	6	256	Lung Cancer	Cancer	2	10	null	0	7,165	4,281.4922	4,088.9082	23	white	13.099609	11	0.768921	0.521973	1	0	0	metastatic	0.8	0.5	no dnr	6	56	12	130	14	40.09375	58	2.299805	0.699951	0.799927	136	7.369141	119	8	2,320	2	null	no(M2 and SIP pres)	1.838867
2,821	83.23596	0	female	0	8	768	ARF/MOSF w/Sepsis	ARF/MOSF	1	14	>$50k	44	6,498	11,080.0312	6,928.82812	26	white	19	28	0.682983	0.589966	1	0	1	no	0.7	0.65	dnr before sadm	0	53	8.099609	60	8	38	278	2.599609	null	0.699951	149	7.459961	169	19	349	null	7	adl>=4 (>=5 if sur)	7
2,822	24.474	0	female	0	22	767	ARF/MOSF w/Sepsis	ARF/MOSF	1	10	null	0	84,800	62,121.2188	47,555.4375	42	hispanic	27.597656	32	0.86792	0.821899	2	0	0	no	0.65	0.65	no dnr	22	67	12.798828	112	58	38.89844	169.375	null	null	0.599976	141	7.439453	121	2	1,375	null	1	SIP>=30	1
2,823	34.47198	0	female	0	24	767	ARF/MOSF w/Sepsis	ARF/MOSF	4	17	$25-$50k	0	89,616	51,243.75	42,702.9062	36.333313	white	36	51	0.647949	0.547974	2	1	0	yes	null	null	no dnr	24	80	21.097656	70	20	36.09375	321	3.299805	null	6.5	134	7.289062	599	91	1,315	null	0	no(M2 and SIP pres)	0
2,824	37.02698	0	male	0	6	766	ARF/MOSF w/Sepsis	ARF/MOSF	1	11	$11-$25k	0	7,813	4,125.1992	4,440.92969	14	white	20	13	0.91394	0.881958	1	0	0	no	0.95	0.8	no dnr	6	65	12	131	52	38.59375	368	2.799805	0.599976	1.899902	150	7.419922	168	78	1,445	null	null	no(M2 and SIP pres)	1.804199
2,825	85.06494	1	male	0	12	94	ARF/MOSF w/Sepsis	ARF/MOSF	2	9	$25-$50k	0	34,245	20,162.6406	19,093.2188	21.5	white	23.898438	38	0.633911	0.531982	3	0	0	yes	0.8	0.7	no dnr	12	96	9.199219	68	10	36.79688	93.75	2.399902	0.399963	0.599976	130	7.399414	82	17	2,030	0	0	adl>=4 (>=5 if sur)	0
2,826	89.74097	0	female	0	9	765	ARF/MOSF w/Sepsis	ARF/MOSF	0	12	$11-$25k	0	17,130	10,323.2422	9,630.22656	10	white	19.097656	28	0.792969	0.724976	1	0	0	no	0.9	0.9	dnr after sadm	1	60	14.798828	110	30	36.59375	195.625	null	null	0.699951	144	7.449219	83	22	null	1	0	no(M2 and SIP pres)	0
2,827	54.09399	1	female	0	20	62	Lung Cancer	Cancer	4	14	$11-$25k	9	16,905	10,727.7969	10,655.5234	7.333332	white	17.199219	13	0.696899	0.408997	1	1	0	metastatic	0.2	0.05	dnr before sadm	-1	110	15.5	146	11	36.19531	268	4.799805	0.399963	2.199707	142	7.329102	111	47	1,275	null	7	adl>=4 (>=5 if sur)	7
2,828	51.38898	1	male	0	17	183	Lung Cancer	Cancer	4	13	$11-$25k	0	41,738	21,054.7188	19,482.7812	13.666664	white	17.5	13	0.728882	0.45697	1	0	0	metastatic	0.7	0.5	no dnr	17	51	4.899414	60	6	35.19531	130.59375	2.899902	0.5	2.299805	141	7.099609	204	80	1,090	0	0	no(M2 and SIP pres)	0
2,829	67.49597	1	female	0	10	123	Lung Cancer	Cancer	2	12	$25-$50k	0	13,784	8,026.0547	7,459.4375	10.5	white	23	35	0.56189	0.23999	1	0	0	metastatic	0.5	0.15	dnr before sadm	-1	113	4.099609	60	25	36.69531	null	4.5	null	1.299805	143	null	60	13	null	2	0	no(M2 and SIP pres)	0
2,830	34.793	0	female	0	7	761	ARF/MOSF w/Sepsis	ARF/MOSF	1	10	under $11k	0	10,315	6,516.2422	5,583.76953	11	black	32.695313	45	0.785889	0.715942	1	0	0	no	0.9	0.9	no dnr	7	122	12.298828	102	8	37.79688	250	3.299805	null	0.799927	134	7.449219	155	23	1,035	0	0	no(M2 and SIP pres)	0
2,831	78.086	1	male	1	11	11	ARF/MOSF w/Sepsis	ARF/MOSF	5	11	$11-$25k	0	43,260	31,237.7344	22,989.7344	49	white	22.796875	26	0.778931	0.706909	1	1	0	no	0.25	0	dnr after sadm	9	73	19	68	26	36.09375	134.6875	null	null	0.799927	135	7.40918	106	14	1,970	null	6	<2 mo. follow-up	6
2,832	54.79797	1	male	1	30	30	Lung Cancer	Cancer	1	null	null	0	43,582	24,543.3906	19,447.6562	14.5	white	18.796875	17	0.696899	0.408997	1	0	0	metastatic	0.5	0.1	no dnr	30	159	9.099609	128	42	36.59375	null	4.599609	0.799927	2	141	null	91	33	3,748	null	null	<2 mo. follow-up	2.833496
2,833	75.12897	1	male	0	8	51	MOSF w/Malig	ARF/MOSF	2	12	null	44	16,763	9,901.5234	9,683.14844	17	white	20.699219	34	0.497986	0.380981	1	0	0	metastatic	0.5	0.25	dnr after sadm	1	93	8	110	20	35.59375	218.3125	4.299805	null	1.299805	142	7.459961	76	23	3,800	1	4	<2 mo. follow-up	4
2,834	71.51794	0	female	0	20	759	ARF/MOSF w/Sepsis	ARF/MOSF	2	10	under $11k	0	41,046	27,401.8438	22,972.2969	12	white	19.898438	43	0.819946	0.759888	3	0	1	no	0.8	0.6	no dnr	20	73	6.099609	80	20	37.79688	null	null	null	0.799927	138	null	71	6	3,000	null	1	no(M2 and SIP pres)	1
2,835	77.88098	1	female	0	15	38	Lung Cancer	Cancer	1	11	null	0	19,490	10,861.7734	14,773.5078	9.666664	white	22.199219	32	0.55188	0.228973	1	0	0	metastatic	0.25	0.5	dnr after sadm	3	63	14.599609	98	30	38.19531	242.5	3.199707	null	1.399902	144	7.419922	174	41	2,280	null	1	<2 mo. follow-up	1
2,836	76.96594	1	male	0	11	23	ARF/MOSF w/Sepsis	ARF/MOSF	0	3	under $11k	9	22,398	13,414.8828	11,736.5156	24	white	18.898438	38	0.816895	0.755981	1	0	0	no	0.5	0.5	no dnr	11	131	25.199219	103	14	38.09375	76.25	2.699707	0.5	0.699951	144	7.469727	144	11	4,815	null	null	<2 mo. follow-up	2.592773
2,837	56.06299	1	male	0	4	343	Lung Cancer	Cancer	4	1	$11-$25k	0	18,205	9,173.8828	2,848.13867	11	white	15.599609	17	0.75293	0.495972	1	1	0	metastatic	0.75	0.4	no dnr	4	121	25.199219	71	12	35	111.42188	2.699707	2.699707	4.299805	146	7.489258	98	76	2,922	0	null	no(M2 and SIP pres)	0.494751
2,838	43.87698	0	female	0	9	753	ARF/MOSF w/Sepsis	ARF/MOSF	1	14	>$50k	0	19,006	12,625.0234	10,735.7734	14.5	white	28.296875	36	0.817993	0.756958	1	0	0	no	0.9	0.9	no dnr	9	108	11.599609	84	20	36.39844	400	4.399414	null	0.399963	138	7.539062	122	2	3,900	1	1	null	1
2,839	73.80396	1	female	0	24	60	Colon Cancer	Cancer	1	null	null	0	34,604	22,847.0469	10,442.0938	20.666656	white	23.398438	31	0.687988	0.395996	1	0	0	metastatic	0.1	0.1	dnr after sadm	20	49	7	63	28	38.39844	null	null	null	1.599854	142	null	84	21	1,935	null	null	null	2.598633
2,840	76.20294	1	male	0	7	24	Lung Cancer	Cancer	5	9	$25-$50k	0	14,896	7,059.4922	8,299.90625	4.5	white	16.699219	18	0.687988	0.395996	1	1	0	metastatic	0.2	0	no dnr	7	70	6	62	14	36.69531	203.3125	4	1	1.399902	142	7.189453	106	42	1,710	5	null	<2 mo. follow-up	3.854981
2,841	71.63599	1	male	0	7	366	Lung Cancer	Cancer	1	10	$11-$25k	0	15,393	8,254.8359	5,255.54688	6.5	white	16.097656	14	0.710938	0.429993	1	0	0	metastatic	0.8	0.2	no dnr	7	113	7.199219	100	20	36.09375	null	null	0.399963	0.899902	136	null	286	14	null	0	6	null	6
2,842	73.18298	0	female	0	12	750	COPD	COPD/CHF/Cirrhosis	3	8	null	0	26,832	null	null	21.5	white	20	33	0.823975	0.713989	1	1	0	no	0.8	0.7	no dnr	12	69	11.898438	108	20	38.59375	null	null	0.699951	0.899902	137	null	81	7	2,850	0	0	no(M2 and SIP pres)	0
2,843	70.90997	0	female	0	24	749	Coma	Coma	0	6	>$50k	100	48,963	27,923	26,209.25	20.666656	white	20.898438	24	0.234985	0.169983	1	0	0	no	null	null	dnr after sadm	5	77	15.398438	120	25	36.09375	null	null	null	1	138	null	123	20	700	null	0	adl>=4 (>=5 if sur)	0
2,844	73.125	1	female	1	82	82	ARF/MOSF w/Sepsis	ARF/MOSF	2	10	$11-$25k	0	282,678	170,951.875	158,507.125	35.25	white	27.097656	72	0.723999	0.638916	1	1	0	no	0.5	0.3	dnr after sadm	82	53	10.599609	59	36	36.69531	100	2.799805	0.599976	0.799927	133	7.5	84	14	500	2	3	SIP>=30	3
2,845	68.78296	1	female	0	16	604	Coma	Coma	3	6	null	44	31,924	20,235.625	16,678.875	18.333328	black	21.097656	42	0.537964	0.467957	1	1	0	no	0.4	0.3	no dnr	16	61	15.798828	135	8	37.69531	175	2.5	0.399963	1	142	7.359375	301	19	5,240	null	1	no(M2 and SIP pres)	1
2,846	71.625	0	male	0	9	746	CHF	COPD/CHF/Cirrhosis	5	12	under $11k	0	11,909	6,340.0938	6,590.71875	11	white	18.398438	22	0.824951	0.714966	1	0	0	yes	1	0.75	no dnr	9	97	6.399414	120	20	39.39844	276.1875	null	null	0.899902	139	7.479492	124	13	null	0	0	no(M2 and SIP pres)	0
2,847	76.96399	1	male	1	23	23	ARF/MOSF w/Sepsis	ARF/MOSF	2	12	$11-$25k	0	114,257	63,974.1562	57,091.875	47.333313	white	32.898438	50	0.572998	0.461975	1	1	0	no	0.5	0.5	dnr after sadm	23	78	29.296875	68	10	35.69531	528.5	2.899902	1.299805	1.099854	139	7.339844	289	33	2,260	null	0	<2 mo. follow-up	0
2,848	45.40698	1	female	0	62	182	ARF/MOSF w/Sepsis	ARF/MOSF	1	12	$25-$50k	0	241,277	146,111.75	127,354.625	46.5	white	34.898438	53	0.459961	0.340942	12	0	0	metastatic	0.01	0	dnr after sadm	21	57	7.5	100	28	36.89844	369	3.099609	null	0.699951	139	7.5	97	5	370	null	0	SIP>=30	0
2,849	89.64496	1	female	1	12	12	ARF/MOSF w/Sepsis	ARF/MOSF	0	18	$25-$50k	0	62,130	34,845	29,211.5469	47.5	white	23.5	45	0.666992	0.569946	5	0	0	no	0.5	0.4	dnr after sadm	10	77	9.099609	128	36	36.69531	null	null	0.399963	0.699951	143	null	104	13	1,050	null	0	<2 mo. follow-up	0
2,850	86.26697	1	male	0	9	25	COPD	COPD/CHF/Cirrhosis	4	9	under $11k	0	9,107	5,198.6875	5,056.62891	13.5	white	21.898438	44	0.700928	0.537964	1	0	0	no	0.1	0.01	dnr before sadm	-1	79	15.398438	63	32	38.69531	316	3.399902	1.599854	0.799927	136	7.509766	203	46	1,910	2	3	<2 mo. follow-up	3
2,851	80.30695	1	female	0	46	299	ARF/MOSF w/Sepsis	ARF/MOSF	1	12	$11-$25k	0	53,620	32,645.9688	17,730.3281	18.5	white	25.097656	38	0.72998	0.646973	1	0	0	no	0.2	0	dnr after sadm	2	71	9.798828	88	26	37.69531	null	null	0.5	1.199951	134	null	169	13	7,650	0	3	no(M2 and SIP pres)	3
2,852	59.06598	0	female	0	4	741	ARF/MOSF w/Sepsis	ARF/MOSF	0	13	>$50k	0	6,445	4,533.3242	3,647.95898	4	white	17	24	0.897949	0.860962	1	0	0	no	0.75	0.75	no dnr	4	57	3.899902	115	25	38	338.0625	3	1.099854	0.5	134	7.549805	126	3	3,550	1	0	no(M2 and SIP pres)	0
2,853	78.05597	1	female	0	23	122	COPD	COPD/CHF/Cirrhosis	2	12	under $11k	0	45,659	28,706.2969	25,184.7344	24.666656	white	29.796875	61	0.602905	0.41394	1	0	0	no	0.5	0.7	no dnr	23	63	18.898438	76	26	36.19531	null	2	null	0.799927	143	null	159	15	750	1	null	no(M2 and SIP pres)	1.166748
2,854	76.04095	0	male	0	4	726	COPD	COPD/CHF/Cirrhosis	3	20	$11-$25k	0	10,911	8,963.7969	7,079.84766	21	white	18.296875	21	0.829956	0.7229	1	0	0	no	0.1	0.05	dnr after sadm	2	77	6.199219	80	20	36.09375	null	3.299805	0.599976	1	138	null	73	23	null	0	null	SIP>=30	0.494751
2,855	78.06696	1	female	0	16	17	CHF	COPD/CHF/Cirrhosis	2	null	null	0	33,427	18,798.0781	17,920.1562	16	white	15.099609	8	0.875	0.792969	1	0	0	no	0.9	0.75	no dnr	16	73	5.099609	100	24	36.79688	null	null	null	1.099854	143	null	92	19	3,500	null	null	<2 mo. follow-up	2.627441
2,856	67.17297	1	male	1	56	56	ARF/MOSF w/Sepsis	ARF/MOSF	2	16	null	0	214,919	133,772.875	119,766.562	44.25	white	31.5	39	0.513916	0.397949	1	1	0	metastatic	0.5	0	dnr after sadm	27	58	6.299805	73	40	38.29688	175	null	null	1.199951	134	7.429688	171	19	2,094	null	0	<2 mo. follow-up	0
2,857	61.88599	1	female	1	3	3	ARF/MOSF w/Sepsis	ARF/MOSF	1	12	under $11k	0	22,855	12,007.4844	9,467.47656	51	white	33.195313	53	0.652954	0.553955	1	1	0	no	null	null	no dnr	3	68	12.599609	66	10	38.5	158	2.799805	0.599976	0.5	138	7.449219	118	21	2,184	null	null	<2 mo. follow-up	2.131348
2,858	76.07397	1	male	0	7	32	COPD	COPD/CHF/Cirrhosis	2	17	null	0	12,470	7,309.4531	6,533.09766	5	white	18.699219	23	0.782959	0.651978	1	0	0	yes	0.5	0.2	dnr after sadm	1	58	3.699707	67	28	38.5	211.65625	1.799805	null	5	139	7.299805	94	109	215	6	7	<2 mo. follow-up	7
2,859	69.81195	0	female	0	6	724	COPD	COPD/CHF/Cirrhosis	2	12	>$50k	0	8,025	4,081.2266	5,767.39844	8	white	15.599609	10	0.886963	0.810913	1	0	0	no	0.6	0.6	dnr after sadm	3	62	8.398438	64	31	37.89844	277.5	null	1	3.199707	140	7.339844	247	58	1,194	0	0	no(M2 and SIP pres)	0
2,860	90.073	1	male	1	7	7	Coma	Coma	1	8	null	100	9,079	5,025.3203	4,395.57812	11	white	27.199219	53	0.014999	0.006	1	0	0	no	0.33	0.33	dnr after sadm	7	73	11.199219	70	15	37.79688	290.4375	null	null	1.699951	132	7.459961	66	15	2,000	null	7	<2 mo. follow-up	7
2,861	74.68298	1	male	1	10	10	ARF/MOSF w/Sepsis	ARF/MOSF	3	13	under $11k	0	31,918	24,692.5	19,064.6719	36	white	28.597656	22	0.620972	0.516968	1	0	0	yes	0.75	0.65	dnr after sadm	5	63	22.699219	117	10	39.39844	91	3	1.799805	1.699951	147	7.419922	181	52	1,535	null	0	<2 mo. follow-up	0
2,862	66.23096	0	male	0	6	722	ARF/MOSF w/Sepsis	ARF/MOSF	2	9	under $11k	0	16,752	11,609.2812	9,339.26562	17	white	16.5	20	0.886963	0.8479	1	0	0	no	1	1	no dnr	6	67	11.199219	140	16	36.5	93.32812	2.799805	5.099609	0.699951	141	7.439453	55	11	1,516	0	null	no(M2 and SIP pres)	0.494751
2,863	72.31995	1	female	1	23	23	MOSF w/Malig	ARF/MOSF	2	10	$11-$25k	0	67,687	38,645.4062	34,834.6875	31.666656	other	33	62	0.396973	0.276978	4	0	0	yes	0.5	0.25	dnr after sadm	5	65	11.398438	70	8	36.19531	178	2.399902	0.599976	2	135	7.479492	69	43	1,745	null	6	<2 mo. follow-up	6
2,864	49.59299	0	female	0	10	717	ARF/MOSF w/Sepsis	ARF/MOSF	1	14	$11-$25k	0	23,496	18,205.4531	16,071.7656	19.5	black	28.5	65	0.794922	0.727905	1	0	0	no	0.7	0.7	no dnr	10	110	9.798828	100	25	36.09375	326.625	4	null	7	144	7.199219	128	127	650	0	0	no(M2 and SIP pres)	0
2,865	72.49298	1	female	0	20	24	MOSF w/Malig	ARF/MOSF	1	12	>$50k	9	40,801	26,217.1719	21,126.7344	33	white	36.195313	42	0.315979	0.202972	1	0	0	yes	0.5	0.1	dnr before sadm	0	63	13.398438	72	22	36.69531	446.625	2.399902	1.399902	3	130	7.389648	107	138	2,230	0	6	<2 mo. follow-up	6
2,866	75.35095	1	female	1	12	12	ARF/MOSF w/Sepsis	ARF/MOSF	5	null	null	44	24,854	17,060.5	14,763.1328	20.5	black	26.5	57	0.54895	0.434998	1	1	1	no	0.6	0.4	dnr after sadm	1	143	8.898438	80	20	36.09375	304.75	null	1.199951	1.599854	142	7.459961	76	19	3,500	null	null	<2 mo. follow-up	6.279297
2,867	65.69495	1	female	0	6	45	Lung Cancer	Cancer	1	null	$11-$25k	0	11,757	5,935.3398	4,202.27734	14	white	17.097656	13	0.704956	0.419983	1	0	0	metastatic	0.75	0.5	no dnr	6	59	29.199219	60	22	35.89844	233.3125	3.199707	0.299988	2.099609	128	7.379883	154	65	3,000	2	0	<2 mo. follow-up	0
2,868	53.89499	1	female	1	8	8	MOSF w/Malig	ARF/MOSF	1	12	$25-$50k	0	36,722	26,371.9219	21,518.4844	34.5	white	35.09375	46	0.345947	0.22998	1	0	0	metastatic	0.45	0.1	dnr after sadm	5	77	8.699219	62	24	36.09375	217.375	3.399902	0.5	1.399902	131	7.359375	176	39	3,175	2	6	<2 mo. follow-up	6
2,869	71.59998	1	female	0	11	358	COPD	COPD/CHF/Cirrhosis	2	18	$25-$50k	0	15,622	8,136.7266	8,532.90625	14.5	white	19.097656	28	0.843994	0.743896	1	0	0	no	0.95	0.8	no dnr	11	73	5.5	60	20	36.69531	null	null	0.599976	1.199951	137	null	102	13	2,600	0	0	no(M2 and SIP pres)	0
2,870	49.495	0	female	0	13	710	CHF	COPD/CHF/Cirrhosis	2	11	$11-$25k	0	45,617	25,077.0781	26,652.125	29.5	black	18.898438	30	0.907959	0.843994	1	0	0	no	0.95	0.9	no dnr	13	47	13.798828	176	8	38.39844	190	2.599609	0.899902	0.799927	146	7.379883	251	16	4,505	1	1	no(M2 and SIP pres)	1
2,871	90.27795	1	female	0	15	42	ARF/MOSF w/Sepsis	ARF/MOSF	2	10	null	0	29,200	18,691.5781	18,738.6406	17.333328	white	19.199219	37	0.789917	0.720947	1	0	0	no	0.6	0.5	dnr after sadm	1	68	7	80	20	35.89844	180	2	6.099609	0.899902	132	7.299805	117	24	1,425	3	6	<2 mo. follow-up	6
2,872	77.14697	1	male	0	15	606	ARF/MOSF w/Sepsis	ARF/MOSF	1	null	null	0	74,562	39,255.3125	40,547.7812	33.333313	white	24.296875	25	0.712891	0.625977	5	0	0	no	0.6	0.216	no dnr	15	48	17	142	26	39	196.65625	3	0.899902	1.5	136	7.429688	370	35	2,221	null	null	null	2.800293
2,873	71.64996	1	male	0	20	196	COPD	COPD/CHF/Cirrhosis	5	12	$25-$50k	0	26,614	14,004.4609	13,184.3438	16	white	17.398438	27	0.827881	0.719971	1	1	0	yes	1	1	dnr after sadm	15	97	11.898438	80	20	35	233.3125	null	null	1.099854	139	7.399414	139	39	550	0	3	SIP>=30	3
2,874	70.17395	0	male	0	13	709	ARF/MOSF w/Sepsis	ARF/MOSF	4	8	under $11k	0	30,650	20,517.8594	16,421.3281	27	white	23.796875	34	0.792969	0.724976	1	0	1	no	0.7	0.5	no dnr	13	93	null	97	24	36.79688	304.3125	null	null	0.899902	141	7.399414	112	29	null	null	7	adl>=4 (>=5 if sur)	7
2,875	44.32898	1	female	0	9	116	MOSF w/Malig	ARF/MOSF	2	18	$25-$50k	0	22,641	14,706.6016	12,632.0469	29	white	24.398438	19	0.654907	0.556885	1	0	0	metastatic	0.6	0.3	no dnr	9	53	20.5	80	30	37.79688	null	null	null	2.5	151	null	135	64	550	0	null	no(M2 and SIP pres)	0.494751
2,876	89.99896	1	female	1	39	39	ARF/MOSF w/Sepsis	ARF/MOSF	0	12	>$50k	0	165,741	null	null	36.5	white	22.898438	48	0.728882	0.644897	1	0	0	no	0.6	0.6	dnr after sadm	1	42	14.599609	76	8	36.59375	230	null	0.599976	1.5	138	7.429688	154	14	3,885	null	5	<2 mo. follow-up	5
2,877	62.42798	1	male	1	7	7	ARF/MOSF w/Sepsis	ARF/MOSF	0	3	under $11k	44	34,412	22,751.5938	18,237.7656	44	black	39.09375	87	0.271973	0.163971	1	0	0	no	0.5	0.5	dnr after sadm	7	70	11.199219	70	26	37	486.625	3.699707	0.399963	1	141	7.339844	95	11	1,800	null	6	<2 mo. follow-up	6
2,878	64.71198	1	male	0	14	84	ARF/MOSF w/Sepsis	ARF/MOSF	4	25	>$50k	0	36,616	21,484	20,967.9688	22.666656	white	25.296875	35	0.78894	0.719971	1	1	0	no	0.9	0.8	no dnr	14	67	1	100	12	35.29688	351	1.899902	4	1.799805	144	7.379883	107	29	845	0	0	no(M2 and SIP pres)	0
2,879	78.75995	0	female	0	18	706	ARF/MOSF w/Sepsis	ARF/MOSF	2	12	under $11k	0	61,702	41,052.375	35,482.4688	12.666664	white	16.898438	37	0.805908	0.741943	14	1	0	no	0.7	0.6	no dnr	18	111	12.699219	128	50	38.29688	261.875	3	null	7.799805	140	7.369141	126	82	1,600	0	0	no(M2 and SIP pres)	0
2,880	86.70197	0	male	0	14	705	ARF/MOSF w/Sepsis	ARF/MOSF	2	12	$11-$25k	0	56,348	32,967.5312	34,517.5	12.666664	white	15.398438	26	0.757935	0.680908	11	0	1	yes	0.9	0.8	no dnr	14	63	0.099991	109	28	36	144	2.199707	0.699951	0.699951	146	7.439453	118	16	3,950	null	2	adl>=4 (>=5 if sur)	2
2,881	67.33496	1	female	0	14	94	MOSF w/Malig	ARF/MOSF	1	15	$25-$50k	0	37,386	27,409.5781	21,789.2812	19.333328	white	34.195313	63	0.344971	0.228973	1	0	0	metastatic	0.3	0.1	dnr after sadm	7	50	7.799805	60	25	39.29688	472.5	2.699707	null	8.5	144	7.349609	76	63	40	0	0	no(M2 and SIP pres)	0
2,882	85.97095	1	female	1	5	5	ARF/MOSF w/Sepsis	ARF/MOSF	2	14	under $11k	0	40,860	23,068.5469	21,470.1406	46	white	26	58	0.623901	0.519897	6	1	0	no	0.5	0.5	dnr after sadm	5	105	null	70	20	36.19531	264	null	null	null	140	7.369141	null	null	3,300	null	2	<2 mo. follow-up	2
2,883	79.01398	1	male	1	58	58	ARF/MOSF w/Sepsis	ARF/MOSF	4	12	$25-$50k	0	234,205	136,209.5	134,112.5	38.75	white	31.699219	55	0.519897	0.403992	6	1	0	no	0.5	0.3	dnr after sadm	44	93	3.799805	100	20	36.59375	null	null	null	1.399902	140	null	118	35	null	null	2	<2 mo. follow-up	2
2,884	50.155	0	male	0	8	702	ARF/MOSF w/Sepsis	ARF/MOSF	2	4	null	0	16,569	11,694.7969	8,973.78906	12.5	black	25.296875	69	0.835938	0.779907	1	0	0	no	0.8	0.7	no dnr	8	53	6.799805	126	38	37.59375	93.32812	3.699707	0.899902	1.399902	147	7.429688	84	28	2,480	0	3	adl>=4 (>=5 if sur)	3
2,885	77.06	0	male	0	10	699	COPD	COPD/CHF/Cirrhosis	2	null	null	0	24,721	16,660.7188	14,882.7031	19	white	26.898438	47	0.678955	0.508911	1	0	0	no	0.8	0.6	no dnr	10	100	5.5	80	20	37.79688	null	null	null	3.5	138	null	179	90	null	null	null	null	3.611816
2,886	81.25897	1	male	1	5	5	ARF/MOSF w/Sepsis	ARF/MOSF	3	null	null	0	17,124	11,060.8125	9,887.57812	20	white	39	69	0.283997	0.174988	1	0	0	yes	0.1	0.05	dnr before sadm	0	125	5.699219	62	30	36.5	205	null	null	1.399902	142	7.489258	98	21	1,350	null	null	<2 mo. follow-up	2.95459
2,887	75.58099	1	female	0	12	186	ARF/MOSF w/Sepsis	ARF/MOSF	4	12	under $11k	0	16,291	10,785.2656	8,693.63281	19	black	21.097656	37	0.767944	0.692993	1	1	0	yes	0.9	0.8	no dnr	12	65	5.399414	64	16	38.09375	285.6875	null	null	2	140	7.379883	103	26	690	null	7	adl>=4 (>=5 if sur)	7
2,888	48.97998	0	female	0	13	695	ARF/MOSF w/Sepsis	ARF/MOSF	0	12	$25-$50k	0	65,038	36,985.9375	36,788.5625	16.5	white	26.296875	27	0.768921	0.694946	16	0	0	no	0.8	0.8	no dnr	13	119	14.898438	62	24	38.79688	167.34375	null	null	2.299805	140	7.369141	125	31	1,965	0	0	no(M2 and SIP pres)	0
2,889	53.75497	0	male	0	19	695	Cirrhosis	COPD/CHF/Cirrhosis	2	16	$25-$50k	9	29,567	15,931.1328	12,398.0547	11.333328	white	25.097656	29	0.714966	0.556885	1	0	0	no	0.8	0.5	no dnr	19	110	6.099609	80	20	36.09375	200	null	null	1.399902	141	7.429688	104	25	null	1	0	no(M2 and SIP pres)	0
2,890	85.46497	1	male	0	27	472	ARF/MOSF w/Sepsis	ARF/MOSF	2	12	$11-$25k	0	76,784	52,937.0625	44,614.4375	33.25	white	26.097656	51	0.619995	0.514893	1	0	0	yes	0.9	0.88	no dnr	27	50	6.799805	98	26	39.29688	235	2.899902	1.199951	1.099854	141	7.419922	283	38	2,155	null	1	adl>=4 (>=5 if sur)	1
2,891	88.20294	1	female	0	10	279	ARF/MOSF w/Sepsis	ARF/MOSF	0	12	$11-$25k	0	20,010	13,632.3438	11,574.7188	17.5	white	27.597656	47	0.637939	0.535889	1	0	0	no	0.9	0.8	dnr after sadm	2	35	11.898438	182	40	38.89844	154.28125	null	null	4.799805	135	7.289062	319	82	625	null	6	null	6
2,892	84.09296	0	male	0	8	693	ARF/MOSF w/Sepsis	ARF/MOSF	3	21	$25-$50k	0	18,630	10,353.1406	8,559.98438	14.5	white	20.5	21	0.74292	0.662964	1	0	0	yes	0.6	0.4	dnr after sadm	1	66	4.5	62	16	36.59375	356	3.199707	5	0.599976	141	7.369141	130	8	4,530	5	6	SIP>=30	6
2,893	83.29895	1	female	0	4	594	CHF	COPD/CHF/Cirrhosis	3	15	null	0	5,048	2,602.3965	2,444.67969	10	white	23.898438	37	0.736938	0.586914	1	1	0	no	0.99	0.78	no dnr	4	68	27.097656	83	24	38	348	null	null	0.899902	141	7.40918	132	24	3,100	0	null	SIP>=30	0.494751
2,894	73.04596	0	female	0	67	692	ARF/MOSF w/Sepsis	ARF/MOSF	1	13	under $11k	0	211,782	126,372.188	103,448.875	44.75	white	24.796875	50	0.765991	0.690918	1	0	0	no	0.25	0.25	no dnr	67	106	14.599609	62	10	37.89844	168.3125	2	0.299988	2.299805	138	7.209961	198	42	1,350	null	7	null	7
2,895	64.77795	0	female	0	36	691	CHF	COPD/CHF/Cirrhosis	9	11	under $11k	0	51,994	30,648.0625	28,667.5625	13.25	white	26.097656	34	0.783936	0.653931	1	1	0	no	0.8	0.7	dnr after sadm	27	47	16.796875	144	28	39.19531	168.3125	1.5	0.599976	2	132	7.289062	102	61	4,030	2	3	adl>=4 (>=5 if sur)	3
2,896	85.75995	1	female	0	11	19	ARF/MOSF w/Sepsis	ARF/MOSF	1	null	under $11k	9	17,840	11,800.1875	10,354.2656	21	white	27.199219	45	0.598999	0.491943	2	0	0	no	0.3	0.1	dnr after sadm	2	72	13.798828	114	28	35.89844	258.3125	3.099609	null	1.5	145	7.469727	221	29	2,275	null	2	<2 mo. follow-up	2
2,897	78.05597	1	male	1	9	9	MOSF w/Malig	ARF/MOSF	3	null	null	0	53,410	30,021.2031	25,955.8281	51	white	43.695313	99	0.070999	0.025997	2	1	0	metastatic	0.5	0.125	dnr after sadm	2	81	18.5	82	28	38.19531	218.34375	3	0.599976	1	133	7.459961	201	41	2,855	null	null	<2 mo. follow-up	3.237793
2,898	75.63599	1	male	0	10	185	COPD	COPD/CHF/Cirrhosis	4	12	$11-$25k	0	26,626	18,746.7031	16,173.3125	20	white	16.296875	23	0.855957	0.762939	1	0	0	no	0.9	0.85	no dnr	10	111	7.299805	80	25	38.79688	316	null	1.5	1.299805	145	7.429688	121	42	3,815	null	0	no(M2 and SIP pres)	0
2,899	71.78094	1	male	0	25	129	COPD	COPD/CHF/Cirrhosis	3	12	$25-$50k	0	46,370	28,051.75	27,075.7188	15.5	white	23.796875	58	0.695923	0.530884	3	0	0	yes	0.3	0.1	no dnr	25	101	0.199982	118	22	34.79688	null	2.199707	2.699707	0.799927	141	null	87	31	1,550	null	0	null	0
2,900	21.20699	0	female	0	10	685	ARF/MOSF w/Sepsis	ARF/MOSF	0	12	null	0	31,912	24,281.7812	19,701.5938	21	white	25.5	43	0.888916	0.848999	3	0	0	no	1	1	no dnr	10	124	10	160	37	39.09375	356	2.699707	4.099609	1	149	7.459961	89	28	1,596	0	0	no(M2 and SIP pres)	0

Subsets and Splits

No community queries yet

The top public SQL queries from the community will appear here once available.